Paul P Dobesh Selected Research

Paul P Dobesh Research Topics

Disease

24	Hemorrhage 05/2024 - 08/2002
14	Venous Thromboembolism 01/2021 - 11/2003
12	Acute Coronary Syndrome 01/2022 - 09/2005
8	Thrombosis (Thrombus) 01/2022 - 08/2008
7	Myocardial Infarction 10/2020 - 07/2002
7	Atrial Fibrillation 01/2019 - 09/2014
5	Stroke (Strokes) 09/2018 - 09/2014
3	COVID-19 01/2022 - 11/2020
3	Thrombocytopenia (Thrombopenia) 01/2016 - 09/2006
3	Sepsis (Septicemia) 10/2014 - 06/2009
3	Coronary Artery Disease (Coronary Atherosclerosis) 03/2014 - 12/2003
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 12/2019
2	Body Weight (Weight, Body) 01/2021 - 09/2009
2	Obesity 01/2021 - 08/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2014 - 12/2012
2	ST Elevation Myocardial Infarction 08/2010 - 07/2002
2	Atherosclerotic Plaque (Atheroma) 08/2010 - 10/2006
2	Stable Angina 12/2007 - 10/2006
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2020
1	Embolism (Embolus) 09/2018
1	Hypertension (High Blood Pressure) 04/2015
1	Rupture 08/2010
1	Infections 02/2010
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 02/2010
1	Inflammation (Inflammations) 02/2010
1	Intermittent Claudication 05/2009
1	Heart Failure 07/2008
1	Disease Progression 12/2007
1	Ischemia 10/2006
1	Pulmonary Embolism 09/2006
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2006
1	Pain (Aches) 07/2006

Drug/Important Bio-Agent (IBA)

21	AnticoagulantsIBA 01/2021 - 08/2008
8	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 10/2004
7	Clopidogrel (Plavix)FDA Link 01/2016 - 10/2006
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020 - 10/2006
6	Vitamin K FDA Link 12/2019 - 10/2004
5	RivaroxabanIBA 08/2023 - 08/2013
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 06/2009
5	Heparin (Liquaemin)FDA LinkGeneric 01/2016 - 09/2005
4	Factor Xa InhibitorsIBA 05/2024 - 09/2015
3	Prothrombin (Factor II)IBA 05/2024 - 01/2021
3	apixabanIBA 08/2023 - 09/2015
3	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021 - 09/2005
3	betrixabanIBA 01/2019 - 01/2018
3	Glycoproteins (Glycoprotein)IBA 08/2008 - 07/2002
2	PRT064445IBA 05/2024 - 01/2021
2	TicagrelorIBA 10/2020 - 01/2016
2	edoxabanIBA 01/2019 - 09/2015
2	Dabigatran FDA Link 01/2019 - 09/2015
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2016 - 12/2007
2	Prasugrel Hydrochloride FDA Link 01/2016 - 09/2009
2	CytokinesIBA 10/2014 - 02/2010
2	thienopyridineIBA 10/2014 - 09/2009
2	CholesterolIBA 10/2014 - 02/2010
2	Platelet Membrane Glycoprotein IIbIBA 08/2008 - 07/2002
2	Fondaparinux (Arixtra)FDA Link 08/2008 - 11/2003
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2007 - 10/2006
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2006 - 11/2005
2	Abciximab (ReoPro)FDA Link 10/2003 - 08/2002
1	CreatinineIBA 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2020
1	SolutionsIBA 01/2020
1	Blood Coagulation Factors (Coagulation Factor)IBA 12/2019
1	AntithrombinsIBA 09/2015
1	Purinergic P2Y Receptor AntagonistsIBA 10/2014
1	cangrelorIBA 03/2014
1	Cytochrome P-450 CYP2C19IBA 03/2014
1	Proton Pump InhibitorsIBA 12/2012
1	Interleukin-6 (Interleukin 6)IBA 02/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010
1	Platelet Activating FactorIBA 02/2010
1	InterleukinsIBA 02/2010
1	Thromboplastin (Tissue Factor)IBA 02/2010
1	Interleukin-8 (Interleukin 8)IBA 02/2010
1	Ticlopidine (Ticlid)FDA LinkGeneric 09/2009
1	Coenzyme A (CoA)IBA 06/2009
1	Oxidoreductases (Dehydrogenase)IBA 06/2009
1	bivalirudin (Angiomax)FDA Link 08/2008
1	1,4-dihydropyridine (dihydropyridine)IBA 07/2008
1	Antihypertensive Agents (Antihypertensives)IBA 07/2008
1	NitratesIBA 12/2007
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2007
1	Ranolazine FDA Link 12/2007
1	Oxygen (Dioxygen)IBA 10/2006

Therapy/Procedure

24	Therapeutics 01/2022 - 07/2002
9	Percutaneous Coronary Intervention 10/2020 - 08/2002
3	Drug Therapy (Chemotherapy) 04/2015 - 10/2006
2	Extracorporeal Membrane Oxygenation 01/2022 - 01/2021
2	Critical Care (Surgical Intensive Care) 01/2022 - 11/2020
2	Length of Stay 01/2021 - 08/2008
1	Thrombolytic Therapy 11/2020
1	Electric Countershock (Cardioversion) 01/2019
1	Catheter Ablation 01/2019
1	Continuity of Patient Care 11/2018
1	Stents 02/2016
1	Secondary Prevention 09/2014
1	Catheters 08/2008
1	Patient Readmission 08/2008
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2006